Psyence Biomedical (Psyence Biomedical) Accounts Payable & Accrued Expense : $1.77 Mil (As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Accounts Payable & Accrued Expense?

Psyence Biomedical's quarterly accounts payable & accrued expense increased from Mar. 2021 ($0.10 Mil) to Mar. 2022 ($0.13 Mil) and increased from Mar. 2022 ($0.13 Mil) to Mar. 2023 ($1.77 Mil).

Psyence Biomedical's annual accounts payable & accrued expense increased from Mar. 2021 ($0.10 Mil) to Mar. 2022 ($0.13 Mil) and increased from Mar. 2022 ($0.13 Mil) to Mar. 2023 ($1.77 Mil).

Psyence Biomedical Accounts Payable & Accrued Expense Historical Data

The historical data trend for Psyence Biomedical's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Accounts Payable & Accrued Expense Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

0.10

0.13

1.77

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
Accounts Payable & Accrued Expense	0.10	0.13	1.77

Psyence Biomedical Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024